Expand ACXP Menu
ACXP MENU

ACXP Stock Summary and Trading Ideas (Acurx Pharmaceuticals | NASDAQ:ACXP)

Acurx Pharmaceuticals (ACXP) Frequently Asked Questions

What does Acurx Pharmaceuticals do?

Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram-positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and Gram-positive bacterial cell death. Its research and development pipeline includes antibiotic product candidates targeting Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and drug-resistant Streptococcus pneumoniae and B. anthracis. It operates in a single segment.

What symbol and exchange does Acurx Pharmaceuticals shares trade?

Acurx Pharmaceuticals trades on the NASDAQ stock market under the symbol ACXP.

What is Acurx Pharmaceuticals stock price doing today?

As of March 26, 2026, ACXP stock price declined to $4.14 with 60,108 million shares trading.

What is Acurx Pharmaceuticals's Beta?

ACXP has a beta of -0.45, meaning it tends to be less sensitive to market movements. ACXP has a correlation of 0.00 to the broad based SPY ETF.

How much is Acurx Pharmaceuticals worth?

ACXP has a market cap of $11.82 million. This is considered a Sub-Micro Cap stock.

What is the highest and lowest price Acurx Pharmaceuticals traded in the last 3 year period?

In the last 3 years, ACXP traded as high as $176.40 and as low as $1.33.

What are the top ETFs holding Acurx Pharmaceuticals?

The top ETF exchange traded funds that ACXP belongs to (by Net Assets): VXF.

Is Acurx Pharmaceuticals (ACXP) a good investment?

ACXP has underperformed the market in the last year with a price return of -51.4% while the SPY ETF gained +14.7%. However, in the short term, ACXP had mixed performance relative to the market. It has outperformed in the last 3 months, returning +19.7% vs -5.2% return in SPY. But in the last 2 weeks, ACXP shares have been beat by the market, returning -31.3% compared to an SPY return of -3.3%.

What are the support and resistance levels for Acurx Pharmaceuticals (ACXP)?

ACXP support price is $3.68 and resistance is $4.86 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ACXP shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes